0001179110-20-005323.txt : 20200430
0001179110-20-005323.hdr.sgml : 20200430
20200430211418
ACCESSION NUMBER: 0001179110-20-005323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200430
DATE AS OF CHANGE: 20200430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHITESIDES GEORGE M
CENTRAL INDEX KEY: 0001233438
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 20838055
MAIL ADDRESS:
STREET 1: C/O ADVANCED MAGNETICS INC
STREET 2: 61 MOONEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
edgar.xml
FORM 4 -
X0306
4
2020-04-28
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001233438
WHITESIDES GEORGE M
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Ordinary Shares
2020-04-28
4
A
0
6635
0
A
6635
D
Ordinary Shares
27650
I
By Family Trust
Ordinary Shares
204963
I
By Trust
Share Option (Right to Buy)
30.14
2020-04-28
4
A
0
6000
0
A
2030-04-27
Ordinary Shares
6000
6000
D
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date.
Brett A. Grimaud, Attorney-in-Fact
2020-04-30